Elliot favus adam feuerstein biography

Founded in 2009, Favus Institutional Research provides healthcare consulting services to institutional investors. We respond to the specific research needs of our institutional investor clients by providing tailored and divergent advice on the healthcare industry.

On this week's Biotech Hangout, hosts Daphne Zohar, Eric Schmidt, Yaron Werber and Luba Greenwood are joined by special guest and STAT reporter, Adam Feuerstein.

On this week's Biotech Hangout, hosts Daphne Zohar, Eric Schmidt, Yaron Werber and Luba Greenwood are joined by special guest and STAT reporter, Adam Feuerstein.

- Public Health, details of history of, Adam, Dr. J., the necropsy of Byron's brain,.

Analyst restates claim that FDA will hold a panel for Provenge, but Dendreon shares hardly react.

STAT's Damian Garde and Adam Feuerstein elaborate on the explosive Biogen story.

FAVUS INSTITUTIONAL RESEARCH LLC, 11/01/, FAERS Case ID# 10/07 Feuerstein, David Bredt, Bik, Trevelyan, CUNY." 12/20/ ,

We use fundamental analysis to evaluate the healthcare sector, with a focus on commercial, clinical data, legal, reimbursement, and regulatory catalysts. The firm is run by Elliot Favus, M.D., who has equity research and institutional investment management experience at Lazard Capital Markets and Och-Ziff Capital Management Group.

Dr. Favus has been working as a healthcare equity research analyst on Wall Street since 2006, at Lazard Capital Markets and Och-Ziff Capital Management Group. Prior to working on Wall Street, Dr. Favus was an Instructor in Medicine at Mount Sinai School of Medicine in New York.

He attended The University of Michigan (B.A.), The University of Chicago Pritzker School of Medicine (M.D.), and the